TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.46, sa.3, ss.764-768, 2016 (SCI-Expanded)
Background/ aim: To evaluate refractive and strabismic results and the efficacy of intravitreal bevacizumab in retinopathy of prematurity (ROP) ineligible for laser therapy.